|
Q3 FY2020
As of Jun 30, 2020
|
Q2 FY2020
As of Mar 31, 2020
|
Q1 FY2020
As of Dec 31, 2019
|
Q4 FY2019
As of Sep 30, 2019
|
Q3 FY2019
As of Jun 30, 2019
|
Q2 FY2019
As of Mar 31, 2019
|
Q1 FY2019
As of Dec 31, 2018
|
Q4 FY2018
As of Sep 30, 2018
|
Q3 FY2018
As of Jun 30, 2018
|
Q2 FY2018
As of Mar 31, 2018
|
Q1 FY2018
As of Dec 31, 2017
|
Q4 FY2017
As of Sep 30, 2017
|
Q3 FY2017
As of Jun 30, 2017
|
Q2 FY2017
As of Mar 31, 2017
|
Q1 FY2017
As of Dec 31, 2016
|
Q4 FY2016
As of Sep 30, 2016
|
Q3 FY2016
As of Jun 30, 2016
|
Q2 FY2016
As of Mar 31, 2016
|
Q1 FY2016
As of Dec 31, 2015
|
Q4 FY2015
As of Sep 30, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash and investments segregated and on deposit for regulatory purposes | ||||||||||||||||||||
| Receivable from brokers, dealers and clearing organizations | ||||||||||||||||||||
| Receivable from clients, net | ||||||||||||||||||||
| Receivable from affiliates | ||||||||||||||||||||
| Other receivables, net | ||||||||||||||||||||
| Securities owned, at fair value | ||||||||||||||||||||
| Investments available-for-sale, at fair value (including $197 million and $99 million of securities pledged as collateral for repurchase agreements at March 31, 2018 and September 30, 2017, respectively) | ||||||||||||||||||||
| Investments available-for-sale, at fair value | ||||||||||||||||||||
| Property and equipment at cost, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Acquired intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Payable to brokers, dealers and clearing organizations | ||||||||||||||||||||
| Payable to clients | ||||||||||||||||||||
| Accounts payable and other liabilities | ||||||||||||||||||||
| Payable to affiliates | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value; 100 million shares authorized, none issued | ||||||||||||||||||||
| Common stock, $0.01 par value; one billion shares authorized; 670 million shares issued; June 30, 2020 – 541 million shares outstanding; September 30, 2019 – 544 million shares outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, common, at cost: June 30, 2020 – 129 million shares; September 30, 2019 – 126 million shares | ||||||||||||||||||||
| Deferred compensation | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
